Anti-thrombogenic medical devices

• US 10,226,366 B2
• Filed: 01/12/2017
• Issued: 03/12/2019
• Est. Priority Date: 03/15/2013
• Status: Active Grant

• Current Assignee: Covidien LP (Medtronic Plc)
• Original Assignee: Covidien LP (Medtronic Plc)
• Inventors: Wainwright, John, Mendelson, Todd, Haggstrom, Kurt, Molaei, Masoud, Schuman, Victoria, Sheu, Min-Shyan
• Primary Examiner(s): Dukert, Brian
• Application Number:
  US15/404,760
• Publication Number:
  US 20170119557A1
• Time in Patent Office: 789 Days
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2/90 characterised by a net-like or mesh-like structure
• CPC Class Codes: A61F 2/966 with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
• CPC Class Codes: A61F 2002/072 Encapsulated stents, e.g. wire or whole stent embedded in lining
• CPC Class Codes: A61F 2002/823 Stents, different from stent-grafts, adapted to cover an aneurysm
• CPC Class Codes: A61F 2002/9665 with additional retaining means
• CPC Class Codes: A61F 2210/0076 multilayered, e.g. laminated structures
• CPC Class Codes: A61F 2230/0069 cylindrical
• CPC Class Codes: A61F 2250/0023 differing in porosity
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: A61F 2310/00389 The prosthesis being coated or covered with a particular material
• CPC Class Codes: B05D 1/18 performed by dipping
• CPC Class Codes: B05D 3/0272 with ovens
• CPC Class Codes: B05D 3/04 by exposure to gases

Abstract

Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.

Claims

1. A medical device for treating an aneurysm, comprising:

a tubular member comprising a plurality of braided filaments that form a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into the aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores having an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, and each of the filaments crossing another of the filaments at a respective crossing point,

the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device, wherein the pores are substantially free of webs formed by an antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by the antithrombogenic material thereby permitting the pores to be substantially free of webs.

2. The medical device of claim 1, wherein the pores have an average pore size that is less than or equal to about 320 microns when the tubular member is in the expanded state.

3. The medical device of claim 2, wherein the pores have an average pore size that is measured using an inscribed circle diameter.

4. The medical device of claim 3, wherein the pores have an average pore size between about 25 microns to about 250 microns.

5. The medical device of claim 1, wherein substantially all surfaces of the filaments possess antithrombogenic surfaces.

6. The medical device of claim 5, wherein the antithrombogenic surfaces are generally uniform over the tubular member.

7. The medical device of claim 1, wherein the antithrombogenic material comprises an antithrombogenic polymer.

8. The medical device of claim 7, wherein the antithrombogenic polymer comprises 2-methacryloyloxyethyl phosphorylcholine (MPC).

9. The medical device of claim 1, wherein the tubular member comprises a heat-set metallic braid.

10. A medical device for treating an aneurysm, comprising:

a hollow body having a plurality of braided filaments each crossing another of the filaments at a respective crossing point, the body being expandable to an expanded state for treatment of the aneurysm, the body having a section for spanning a neck of the aneurysm and a plurality of pores located between the filaments, the pores in the section having a first average pore size of less than about 500 microns when the body is in the expanded state, the filaments of the section possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device, wherein the pores in the section are substantially free of webs formed by an antithrombogenic material such that fewer than 5% of the crossing points have webs formed by the antithrombogenic material thereby permitting the pores in the section to be substantially free of webs.

11. The medical device of claim 10, wherein the first average pore size is less than or equal to about 320 microns.

12. The medical device of claim 10, wherein the first average pore size is measured using an inscribed circle diameter.

13. The medical device of claim 12, wherein the first average pore size is between about 25 microns and about 250 microns.

14. The medical device of claim 10, wherein the first average pore size is the average size of the pores in the section.

15. The medical device of claim 10, wherein the hollow body comprises a tubular member.

16. The medical device of claim 10, wherein substantially all surfaces of the filaments possess antithrombogenic surfaces.

17. The medical device of claim 10, wherein the antithrombogenic material comprises an antithrombogenic polymer.

18. The medical device of claim 17, wherein the antithrombogenic polymer comprises 2-methacryloyloxyethyl phosphorylcholine (MPC).

19. The medical device of claim 10, wherein the body comprises a heat-set metallic braid.

20. The medical device of claim 10, wherein the body is self-expanding.